These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 16824633
1. Sulfonylurea therapy is associated with increased NT-proBNP levels in the treatment of type 2 diabetes. Tildesley HD, Aydin CM, Ignaszewski A, Strelzow JA, Yu E, Bondy G. Int J Cardiol; 2007 Feb 14; 115(3):312-7. PubMed ID: 16824633 [Abstract] [Full Text] [Related]
2. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease. Hess G, Runkel S, Zdunek D, Hitzler WE. Clin Lab; 2005 Feb 14; 51(3-4):167-72. PubMed ID: 15819172 [Abstract] [Full Text] [Related]
3. N-terminal pro-B-type natriuretic peptide (NT-proBNP) in HIV-1 infected individuals on HAART. Berg T, Zdunek D, Stalke J, Dupke S, Baumgarten A, Carganico A, Hess G. Eur J Med Res; 2007 Apr 26; 12(4):152-60. PubMed ID: 17509959 [Abstract] [Full Text] [Related]
5. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients. Goei D, Flu WJ, Hoeks SE, Galal W, Dunkelgrun M, Boersma E, Kuijper R, van Kuijk JP, Winkel TA, Schouten O, Bax JJ, Poldermans D. Anesth Analg; 2009 Nov 26; 109(5):1403-8. PubMed ID: 19843778 [Abstract] [Full Text] [Related]
6. N-terminal pro-B-type natriuretic peptide as a predictor of repeat coronary revascularization. Sir JJ, Chung WY, Hwang SJ, Kang HJ, Cho YS, Koo BK, Chae IH, Choi DJ, Kim HS, Sohn DW, Kim CH, Oh BH, Park YB, Choi YS. Int J Cardiol; 2008 Jun 06; 126(3):322-32. PubMed ID: 17544525 [Abstract] [Full Text] [Related]
7. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD. J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563 [Abstract] [Full Text] [Related]
8. Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism. Ogard CG, Engelmann MD, Kistorp C, Nielsen SL, Vestergaard H. Clin Endocrinol (Oxf); 2005 Nov 13; 63(5):493-8. PubMed ID: 16268799 [Abstract] [Full Text] [Related]
9. Obese and nonobese patients with essential hypertension show similar N-terminal proBNP plasma levels. Cortés R, Otero MR, Morillas P, Roselló-Lletí E, Grigorian L, Martínez-Dolz L, de Burgos FG, Calabuig JR, Soria F, Lozano T, Portolés M, Bertomeu V. Am J Hypertens; 2008 Jul 13; 21(7):820-5. PubMed ID: 18443568 [Abstract] [Full Text] [Related]
10. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population. Lam CS, Burnett JC, Costello-Boerrigter L, Rodeheffer RJ, Redfield MM. J Am Coll Cardiol; 2007 Mar 20; 49(11):1193-202. PubMed ID: 17367664 [Abstract] [Full Text] [Related]
11. Correlation of B type natriuretic peptides with clinical and echocardiographic parameters in heterogeneous population of patients with symptoms suggestive of heart failure. Piechota WN, Piechota WT, Bejm J, Wierzbowski R, Michałkiewicz D. Adv Med Sci; 2006 Mar 20; 51():164-7. PubMed ID: 17357300 [Abstract] [Full Text] [Related]
12. N-terminal pro-brain natriuretic peptide (NT-proBNP) in Type 2 diabetes with left ventricular dysfunction. Kim JY, Lee EY, Jee JH, Lee BW, Chung JH, Jeun ES, Min YK, Lee MS, Kim KW, Lee MK. Diabetes Res Clin Pract; 2007 Sep 20; 77 Suppl 1():S238-42. PubMed ID: 17490778 [Abstract] [Full Text] [Related]
13. Hyperthyroidism may affect serum N-terminal pro-B-type natriuretic peptide levels independently of cardiac dysfunction. Arikan S, Tuzcu A, Gokalp D, Bahceci M, Danis R. Clin Endocrinol (Oxf); 2007 Aug 20; 67(2):202-7. PubMed ID: 17547691 [Abstract] [Full Text] [Related]
17. Plasma N-terminal Pro-Brain Natriuretic Peptide (Nt-proBNP) level and prognosis after myocardial infarction in diabetes. Vergès B, Zeller M, Beer JC, Cottin Y, RICO survey working group. Diabetes Metab; 2008 Feb 20; 34 Suppl 1():S10-5. PubMed ID: 18358421 [Abstract] [Full Text] [Related]
18. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease. Rothenbacher D, Koenig W, Brenner H. Arch Intern Med; 2008 Feb 20; 166(22):2455-60. PubMed ID: 17159010 [Abstract] [Full Text] [Related]
19. NT-proBNP in chronic hypercapnic respiratory failure: a marker of disease severity, treatment effect and prognosis. Budweiser S, Luchner A, Jörres RA, Heinemann F, Hitzl AP, Schmidbauer K, Riegger G, Pfeifer M. Respir Med; 2007 Sep 20; 101(9):2003-10. PubMed ID: 17532200 [Abstract] [Full Text] [Related]
20. [Factors associated plasma B type natriuretic peptide and N-terminal pro-B-type natriuretic peptide levels]. Chen Y, Yao CL, Shimada T. Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Sep 20; 36(9):825-30. PubMed ID: 19102867 [Abstract] [Full Text] [Related] Page: [Next] [New Search]